Neumora Therapeutics, Inc. share price logo

Neumora Therapeutics, Inc. Share Price

NASDAQ: NMRA

Small Cap

$2.23

-0.04

(-1.98%)

as on

Neumora Therapeutics, Inc. Stock Performance

as on December 6, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $2.21
    $2.3
    downward going graph

    0.90%

    Downside

    3.14%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.61
    $11.57
    downward going graph

    72.60%

    Downside

    418.83%

    Upside

    downward going graph

Neumora Therapeutics, Inc. share price movements today

Previous Close
$2.27
Open
$2.25
Volume
617.5K
Day's Low - High
$2.21 - $2.3
52 Week Low - High
$0.61 - $11.57

Neumora Therapeutics, Inc. Historical Returns

1 Month Return
-13.95 %
3 Month Return
+ 32.14 %
1 Year Return
-78.43 %
3 Year Return
0 %
5 Year Return
0 %

Neumora Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Neumora Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$386.6M

EPS (TTM)

-1.4305

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-240.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-104.35%

Neumora Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neumora Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$386.6MNANA0.00%
BUY$43.5B408.22%-16.34-264.83%
BUY$61.5B253.6%1661.931.36%
BUY$117.3B99.49%32.1631.35%
BUY$76.6B45.87%17.3132.13%

Stock Returns calculator for Neumora Therapeutics, Inc. Stock including INR - Dollar returns

The Neumora Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Neumora Therapeutics, Inc. investment value today

Current value as on today

₹27,610

Returns

₹72,390

(-72.39%)

Returns from Neumora Therapeutics, Inc. Stock

₹78,328 (-78.33%)

Dollar Returns*

₹5,939 (+5.94%)

Analyst Recommendation on Neumora Therapeutics, Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Neumora Therapeutics, Inc.. Average target price of $9.17

Neumora Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Neumora Therapeutics, Inc..

What analysts predicted

75.68%UPSIDE

Target Price

$9.17

Current Price

$2.23

Analyzed by

12 Analysts

Target

$9.17

Neumora Therapeutics, Inc. target price $9.17, a slight upside of 75.68% compared to current price of $2.23. According to 12 analysts rating.

Neumora Therapeutics, Inc. Stock’s Investor Sentiment and Interest

Search interest for Neumora Therapeutics, Inc. Stock has increased by 2% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:2% versus previous 30 day period

Neumora Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-1
0
0
0
-
-
-
-
-5
Operating Income
-42
-56
-50
-60
-63
-76
-62
-70
-54
-57
EBITDA
-41
-56
-108
-59
-63
-76
-62
-70
-54
-55
Interest Expense
-
-
-
-
-
-
-
-
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-38
-53
-108
-53
-58
-72
-58
-67
-52
-56
Income Tax Expense
-3
-4
0
-6
0
0
-
0
0
-
Net Income
-38
-53
-108
-53
-58
-72
-58
-67
-52
-56
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Neumora Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
Gross Profit
-
-1
-2
0
-
Operating Income
-95
-237
-135
-188
-263
EBITDA
-95
-236
-135
-187
-262
Interest Expense
-
-
-
-
-
Depreciation
0
0
0
0
0
Income Before Tax
-99
-237
-130
-235
-243
Income Tax Expense
0
0
-4
0
0
Net Income
-99
-237
-130
-235
-243
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Neumora Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-53
-108
-53
-58
-72
-58
-67
-52
-56
Operating Cash Flow
-47
-51
-42
-56
-33
-50
-59
-52
-46
Investing Cash Flow
23
13
-150
21
156
-98
44
30
51
Financing Cash Flow
232
0
1
2
1
15
-
18
0
Change in Cash
208
-38
-191
-32
125
-133
-15
-3
4

Neumora Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-99
-237
-130
-235
-243
Operating Cash Flow
-26
-75
-114
-163
-182
Investing Cash Flow
-11
0
-168
64
-70
Financing Cash Flow
230
293
115
231
21
Change in Cash
192
217
-167
133
-231

Insights on Neumora Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 170.6% return, outperforming this stock by 249.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, NMRA stock has moved down by -8.3%

About Neumora Therapeutics, Inc.

Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Navacaprant is being investigated in the KOASTAL pivotal Phase 3 program, evaluating navacaprant monotherapy in patients with moderate to severe MDD. The Company's next advanced product candidate is NMRA-511, which is a highly selective, novel antagonist of the vasopressin 1a receptor (V1aR) being developed for the treatment of agitation associated with dementia due to Alzheimer's disease (AD).
OrganisationNeumora Therapeutics, Inc.
Headquarters490 Arsenal Way, Watertown, MA, United States, 02472
CEODr. Daljit Singh Aurora Pharm.D.
E-voting on sharesClick here to vote

Key Management of Neumora Therapeutics, Inc.

Name

Title

Dr. Daljit Singh Aurora Pharm.D.

Chief Operationg & Development officer

Mr. Michael Lee Milligan

CFO & Principal Accounting Officer

Mr. Jason G. Duncan J.D.

Chief Legal & Administrative Officer

Ms. Amy Sullivan

Chief Human Resources Officer

Ms. Lori Houle

Chief Technical Operations & Quality Officer

Dr. Joshua Pinto Ph.D.

President

Ms. Carol Suh

Co-Founder & Chief Strategy Officer

Dr. Nicholas Brandon Ph.D.

Chief Scientific Officer

Mr. Pablo Gersberg

Chief Information Officer

Helen Rubinstein

Head of Investor Relations

FAQs

What is Neumora Therapeutics, Inc. share price today?

Neumora Therapeutics, Inc. share price today is $2.23 as on at the close of the market. Neumora Therapeutics, Inc. share today touched a day high of $2.3 and a low of $2.21.

What is the 52 week high and 52 week low for Neumora Therapeutics, Inc. share?

Neumora Therapeutics, Inc. share touched a 52 week high of $11.57 on and a 52 week low of $0.61 on . Neumora Therapeutics, Inc. stock price today i.e. is closed at $2.23,which is 80.73% down from its 52 week high and 264.98% up from its 52 week low.

What is Neumora Therapeutics, Inc.'s market capitalisation today?

Neumora Therapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Neumora Therapeutics, Inc. Stock (NMRA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Neumora Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neumora Therapeutics, Inc. Shares that will get you 0.6726 shares as per Neumora Therapeutics, Inc. share price of $2.23 per share as on December 6, 2025 at 2:29 am IST.

What is the minimum amount required to buy Neumora Therapeutics, Inc. Stock (NMRA) from India?

Indian investors can start investing in Neumora Therapeutics, Inc. (NMRA) shares with as little as ₹89.896 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.96 in Neumora Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Neumora Therapeutics, Inc. share’s latest price of $2.23 as on December 6, 2025 at 2:29 am IST, you will get 4.4843 shares of Neumora Therapeutics, Inc.. Learn more about fractional shares .